Skin, hair and nail fungal infections

Infectious Diseases in Clinical Practice

Volumn 10, Issue 2, 2001, Pages 117-122

  Aly, Raza ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84863956599     PISSN: 10569103     EISSN: 15369943     Source Type: Journal    
DOI: 10.1097/00019048-200102000-00009     Document Type: Article

References (40)

1. Lesher JL, Babel DE, Stewart DM, Jones TM, Kaminester L, Goldman M, Weintraub JS. Butenfanine 1% cream in the treatment of tinea cruris: a multicenter, vehicle-controlled, double-blind trial. J Am Acad Dermatol 1997; 36 (suppl.):S20-S24.
2. Sabota J, Brodell R, Rutecki GW, Hoppes WL. Severe tinea barbae due to Trichophyton verrucosum infection in dairy farmers. Clin Infect Dis 1996; 23: 1308-1310.
3. Faergemann J, Mork NJ, Haglund A, Odegard T. A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris. Br J Dermatol 1997; 136: 575-577.
4. Bakos L, Brito AC, Castro LCM, Gontijo B, Lowy G, Reis CMS et al. Open clinical study of the efficacy and safety of terbinafine cream 1% in children with tinea corporis and tinea cruris. Pediatr Infect Dis J 1997; 16: 545-548.
5. Aly R. Tinea pedis: epidemiology, clinical manifestation, pathophysiology and therapy. In: Cutaneous infection and therapy. Aly R, Beutner KR, Maibach HI (editors). New York: Marcel Dekker; 1997; pp. 139-148.
6. Zaias N, Rebell G. Chronic dermatophytosis caused by Trichophyton rubrum. J Am Acad Dermatol 1996; 35 (suppl.):S17-S20.
7. Savin R, Devillez RL, Elewski B, Hong S, Jones T, Lowe N et al. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter double blind trial. J Am Acad Dermatol 1997; 36 (suppl.):S15-S19.
8. Tschen E, Elewski B, Gorsulowsky DC, Pariser DM. Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream. J Am Acad Dermatol 1997; 36 (suppl.):S9-S14.
9. Gupta AK, Dedoncker P, Heremans A, Stoffels P, Pierard GE, Decroix J et al. Intraconazole for the treatment of tinea pedis: a dosage of 400 mg/day given for 1 week is similar in effiacy to 100 or 200 mg/day given for 2 to 4 weeks. J Am Acad Dermatol 1997; 36: 789-792.
10. Elewski BE. Onychomycosis caused by Scytalidium dimidiatum. J Am Acad Dermatol 1996; 35: 789-792.
11. Ploysangam T, Lucky AW. Childhood white superficial onychomycosis caused by Trichophyton rubrum: report of seven cases and review of the literature. J Am Acad Dermatol 1997; 36: 29-32.
12. Gupta AK, Lynde CW, Jain HC, Sibbald RS, Elewski BE, Daniel CR et al. A higher prevalence of onychomycosis in psoriatics compared with non-psoriatics: a multicenter study. Br J Dermatol 1997; 136: 386-789.
13. Aly R, Berger T. Common superficial infections in patients with AIDS. Clin Infect Dis 1996; 22 (suppl.):S128-S132.
14. Gregory N. Special patient populations: onychomycosis in the HIV-positive patient. J Am Acad Dermatol 1996; 35 (suppl.):S13-S16.
15. Rich P. Special patient populations: onychomycosis in the diabetic patient. J Am Acad Dermatol 1996; 35 (suppl.):S10-S12.
16. Pierard GE, Arrese JE, De Doncker P, Pierard-Franchimont C. Present and potential diagnostic techniques. J Am Acad Dermatol 1996; 34: 273-277.
17. Odom R, Daniel R, Aly R. A double-blind randomized comparison of itraconazole capsules and placebo in the treatment of onychomycosis of the nail. J Am Acad Dermatol 1996; 35: 110-111.
18. De Doncker P, Cecroix J, Pierard GE, Roelant D, Woesenborghs R, Jacqmin P et al. Antifungal pulse therapy for onychomycosis. Arch Dermatol 1996; 132: 34-41.
19. Odom RB. New therapies for onychomycosis. J Am Acad Dermatol 1996; 35 (suppl.):S26-S30.
20. Odom RB, Aly R, Scher RK, Daniel R, Elewski BE, Zaias N et al. A multicenter, plaecbo-controlled, double-blind study of intermittent therapy with itraconazole for the treatment of onychomycosis of the fingernail. J Am Acad Dermatol 1997; 36: 231-235.
21. Baran RL, Aly R. Diagnosis and new treatment in the management of onycomycosis. In: Cutaneous infection and therapy. Aly R, Beutner KR, Maibach HI (editors). New York: Marcel Dekker; 1997. pp. 149-156.
22. Havu V, Brandt H, Heikkila H, Hollmen A, Oksnan R, Rantanen T et al. A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis. Br J Dermatol 1997; 136: 230-234.
23. De Doncker PRG, Schner RK, Baran RL, Decroix J, Degreef HJ, Roseeuw DI et al. Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: a multicenter study with 36 patients. J Am Acad Dermatol 1997; 36: 173-177.
24. Tosti A, Piraccini BM, Stinchi C, Lorenzi S. Onychomycosis due to Scopulariopsis brevicaulis: clinical features and response to systemic antifungals. Br J Dermatol 1996; 135: 799-802.
25. Tosti A, Piraccini BM, Stinchi C, Venturo N, Bardazi F, Colombo MD. Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and interrnittent itraconazole therapy. J Am Acad Dermatol 1996; 34: 595-600.
26. Assaf RR, Elewski BE. Intermittent fluconazole dosing in patients with onychomycosis: results of a pilot study. J Am Acad Dermatol 1996; 35: 216-219.
27. Wilmington M, Aly R, Frieden IJ. Trichophyton tonsurans tinea capitis in the San Francisco Bay Area: increased infection demonstrated in a 20-year survey of fungal infections from 1974 to 1994. J Med Vet Mycol 1996; 34: 285-287.
28. Hay RJ, Clayton YM, Desilva N, Midgley G, Rossor B. Tinea capitis in south-east London. A new pattern of infection with public health implications. Br J Dermatol 1996; 135: 955-958.
29. Fuller LC, Child FC, Higgins EM. Tinea captiis in south-east London: an outbreak of Trichophyton tonsurans infections. Br J Dermatol 1997; 136:139.
30. Gupta AK, Alexis ME, Raboobee N, Hofstader SLR, Lynde CW, Adam P et al. Itraconazole pulse therapy is effective in the treatment of tinea capitis in children: An open multicenter study. Br J Dermatol 1997; 136: 1-4.
31. Solomon BA, Collin R, Sharma R, Silverberg N, Jain AR, Sedgh J, Laude TA. Fluconazole for the treatment of tinea capitis in children. J Am Acad Dermatol 1997; 37: 274-275.
32. Bournerias I, De Chauvin MF, Datry A, Bhambrette I, Carriere J, Devidas A et al. Unusual Microsporum canis infections in adult HIV patients. J Am Acad Dermatol 1996; 35: 808-816.
33. Kullavanijaya P, Reangchainam S, Ungpakorn R. Randomized single-blind study of efficacy and tolerability of terbinafine in the treatment of tinea capitis. J Am Acad Dermatol 1997; 37: 272-273.
34. Desgarennes MCP, Godoy MR, Palencia AB. Therapeutic efficacy of terbinafine in the treatment of three children with Trichophyton tonsurans. J Am Acad Dermatol 1996; 35: 114-116.
35. McGiniis MR. Superficial and cutaneous phaeohyphomycosis in immunocompetent patients. In: Cutaneous infection and therapy. Aly R, Beutner KR, Maibach HI (eds): New York: Marcel Dekker; 1997; pp. 199-209.
36. Hecker MS, Weinberg JM, Bagheri B, Tangoren IA, Rudikoff D, Rudoph RI, Phelps RG. Cutaneous Paecilomyces lilacinus infection: report of two novel cases. J Am Acad Dermatol 1997; 37: 270-271.
37. Orth B, Frei R, Itin PH, Rinaldi MG, Speck B, Gratwohl A, Widmer AF. Outbreak of invasive mycoses caused by Paecilomyces lilacinus from a contaminated skin lotion. Ann Intern Med 1996; 125: 799-806.
38. Wirth F, Perry R, Eskenazi A, Schwalbe R, Kao G. Cutaneous mucormycosis with subsequent visceral dissemination in a child with neutropenia: a case report and review of the pediatric literature. J Am Acad Dermatol 1997; 36: 336-341.
39. Leong KW, Crowley B, White B, Crotty GM, Obriain DS, Keane C, McCann SR. Cutaneous mucormycosis due to Absidia corymbifera occurring after bone marrow transplantation. Bone Marrow Transplant 1997; 19: 513-515.
40. Sigler L, Sumerbell RC, Poole L, Wieden M, Sutton DA, Rinaldi MG et al. Invasive Nattrassia mangiferae infections: case report, literature review, and therapeutic and taxonomic appraisal. J Clin Microbiol 1997; 35: 433-440.